Reportedly, Novella will assume the use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.
OSI had previously announced plans to consolidate its US operations onto a single campus located in Ardsley, New York. OSI has begun consolidation of approximately 350 current US employees from its facilities in Melville and Farmingdale, New York, Boulder, Colorada, and Cedar Knolls, New Jersey.
Colin Goddard, CEO of OSI, said: “This is a win-win agreement between OSI and Novella and for the OSI Boulder employees who have chosen not to relocate with the company. As we execute our plan to capture the full strategic value of our oncology franchise and to simplify our business by bringing all our US employees onto one campus, the expanded agreement will provide continuity of clinical operations, biostatistics, medical writing and regulatory affairs for certain ongoing clinical studies as the company transitions functions to its new campus in Ardsley, New York.”